omar
Small moleculeexperimentalImaging agent
Umar ibn al-Khattab, also spelled Omar, was the second Rashidun caliph, ruling from August 634 until his assassination in 644. He succeeded Abu Bakr and is regarded as a senior companion and father-in-law of the Islamic prophet Muhammad. — Wikipedia
Clinical trial activity
3 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Sep 14, 2017 (NCT03204305)
Timeline
2010s
- Jan 1, 2017
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Cannabinoid CB1 receptorRadiopharmaceutical
CNR1 radiopharmaceutical
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05683184 | Phase 1 | Mar 10, 2023 | National Institute on Drug Abuse (NIDA), Yale University |
| NCT03539575 | N/A | May 1, 2018 | National Institute on Drug Abuse (NIDA), National Institutes of Health (NIH), Yale University |
| NCT03204305 | Early Phase 1 (Phase 1) | Sep 14, 2017 | Johns Hopkins University, National Institute on Drug Abuse (NIDA) |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Institute on Drug Abuse (NIDA) | Government | 3 | 0 | 2 | 2017 |
| Yale University | Academic/Hospital | 2 | 2 | 2 | 2018 |
| Johns Hopkins University | Academic/Hospital | 1 | 1 | 1 | 2017 |
| National Institutes of Health (NIH) | Government | 1 | 0 | 1 | 2018 |
4 organizations
Page 1 / 1